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ABSTRACT The cdc25 phosphatases play key roles in cell
cycle progression by activating cyclin-dependent kinases. Two
members of the 14-3-3 protein family have been isolated in a
yeast two-hybrid screen designed to identify proteins that
interact with the human cdc25A and cdc25B phosphatases.
Genes encoding the human homolog ofthe 14-3-3e protein and
the previously described 14-3-3f8 protein have been isolated in
this screening. 14-3-3 proteins constitute a family of well-
conserved eukaryotic proteins that were originally isolated in
mammalian brain preparations and that possess diverse
biochemical activities related to signal transduction. We
present evidence that indicates that cdc25 and 14-3-3 proteins
physically interact both in vitro and in vivo. 14-3-3 protein does
not, however, affect the phosphatase activity of cdc25A. Raf-1,
which is known to bind 14-3-3 proteins, has recently been
shown to associate with cdc25A and to stimulate its phos-
phatase activity. 14-3-3 protein, however, has no effect on the
cdc25A-kinase activity of Raf-1. Instead, 14-3-3 may facilitate
the association of cdc25 with Raf-1 in vivo, participating in the
linkage between mitogenic signaling and the cell cycle ma-
chinery.
In eukaryotic cells, the cyclin-dependent kinases (cdks) regu-
late cellular functions critical to passage through successive
phases of the cell cycle (1). The activity of these kinases is
regulated both by association with ancillary proteins and by
phosphorylation. Foremost among cdk-associated proteins are
the cyclins, which function as positive regulatory subunits for
specific members of the cdk family. Several recently described
cdk inhibitors, p15 (2), p16 (3), p21 (4-6), and p27 (7, 8), also
physically interact with cdks. The expression of these proteins
increases in response to cellular damage or extracellular
growth inhibitory signals, resulting in the inhibition of kinase
activity.
cdk activity is also regulated by phosphorylation. Phosphor-
ylation of a threonine residue within the catalytic domain of
cdks by the cdk-activating kinase (CAK) is required for kinase
activity (9). Inhibitory phosphorylation of threonine and ty-
rosine residues in the ATP-binding site of most cdks inhibits
kinase activity (10). These inhibitory sites are conserved
between fission yeast and several metazoan cdks and are found
near the N termini, usually at residues Thr-14 and Tyr-15 (11).
The phosphorylation state of Thr-14 and Tyr-15 residues of
fission yeast cdc2 is a major determinant of the onset of mitosis
and is controlled by the opposing actions of the weel/mikl
kinases and the cdc25 phosphatase (12-15). weel kinases are
now known from many species (16-18) and have been shown
to phosphorylate Tyr-15 (12, 13). cdc25 phosphatases, al-
though weakly related to the main family of protein phos-
phatases, have been shown to specifically dephosphorylate
Thr-14 and Tyr-15 (15, 19-23). Yeasts have a single cdc25 gene
(16, 24), whereas human cells possess three related cdc25
genes: CDC25A, -B, and -C (25, 26).
The activity of the cdc25 phosphatases is also regulated by
phosphorylation. In human cells, cdc25C is activated at the
onset of mitosis by cdc2-cyclin B phosphorylation (27). Since
cdc25C phosphatase activity stimulates cdc2 kinase activity,
phosphorylation by cdc2-cyclin B may result in the formation
of an auto-amplification loop with increased cdc25C activity
further activating cdc2 kinase activity. cdc25A, which plays a
crucial role early in the cell cycle (28), has been shown to be
phosphorylated by cdk2-cyclin E at the G1/S transition (29).
Recently, the Raf-1 protooncogene kinase has been found to
form a tight complex with cdc25 phosphatases both in somatic
cells and in Xenopus oocytes (30). Raf-1-dependent kinase
activity phosphorylates and stimulates cdc25A activity. This
constitutes a major link between mitogenic signaling and cell
cycle control.
To identify other potential regulators of cdc25, a yeast
two-hybrid protein interaction screening was undertaken to
identify proteins that interact with the human cdc25 phos-
phatases. Two interacting clones were found to encode 14-3-3
isoforms.t These proteins are members of a family of proteins
that are known to associate with components of several signal
transduction pathways, including the Raf-1 kinase cascade.
This interaction is likely to play some role in linking mitogenic
signaling to the regulation of cdc25 activity.
MATERIALS AND METHODS
Two-Hybrid Screens. Saccharomyces cerevisiae strains HF7C
(31) and L40 (32) were used as hosts for two-hybrid vectors.
HeLa cell two-hybrid cDNA libraries were gifts of G. Hannon
(Cold Spring Harbor Laboratory, Cold Spring Harbor, NY).
cdc25A and cdc25B were fused to the sequence encoding the
GAL4 DNA-binding domain of pGBT9. Yeast cells were
simultaneously transformed with GAL4 DNA-binding domain
(GAL4BD) fusion plasmids and GAL4 transcriptional activa-
tion domain (GAL4AD) fusion plasmids. Leu+ Trp+ transfor-
mants, which contain both GAL4BD and GAL4AD fusion
plasmids, were streaked on plates with or without histidine to
determine whether the encoded proteins interacted. Yeast
cells were grown in YPD (2% glucose/2% peptone/1% yeast
extract) or synthetic minimal media (2% glucose/0.67% yeast
nitrogen base, with appropriate auxotrophic supplements) by
using standard techniques. Plasmids carrying sequences en-
coding Ras and Raf-1 fusions (33) were gifts of L. VanAelst
(Cold Spring Harbor Laboratory).
Binding Experiments. A fusion of maltose-binding protein
(MBP) and 14-3-313 for expression in bacteria was constructed
by removing the open reading frame from pGBT9-14-3-3,B by
using PCR with primers to flanking DNA. The resulting
fragment was inserted into the EcoRI and Pst I sites of
pBluescript KS (-) (Stratagene), producing plasmid p14-3-
3KS-. In vitro translation and DNA sequence analysis con-
firmed that the wild-type 14-3-31 open reading frame had been
subcloned without the introduction of errors. The MBP-14-
3-3,B fusion was constructed by inserting the entire 14-3-313
Abbreviations: cdk, cyclin-dependent kinase; MBP, maltose-binding
protein; GST, glutathione S-transferase.
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tThe sequence reported in this paper has been deposited in the
GenBank data base (accession no. U20972).
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open reading frame into pMAL-c2 (New England Biolabs).
Construction of the glutathione S-transferase (GST)-cdc25A
fusion has been described (25). Each protein was purified on
either glutathione-Sepharose or amylose-Sepharose columns
by using standard procedures. Purified proteins were incu-
bated at approximate final concentrations of 500 nM in 50mM
Tris-HCl, pH 7.5/150mM NaCl/0.5% Nonidet P-40 for 30 min
on ice. Complexes were subsequently precipitated by the
addition of 50 Al of a 1:1 slurry of glutathione-Sepharose and
the above buffer. Beads were washed four times with the above
buffer, heated to 95°C in sample buffer (55), and subjected to
SDS/PAGE and immunoblotting. The immunoblot was
probed with anti-MBP-antibody (New England Biolabs).
Staphylococcal proteinA coupled with horseradish peroxidase
HRP (Amersham) and the ECL reagent (Amersham) were
used to detect bound antibody in all immunoblots.
Immunoprecipitation and Antibody Production. HeLa cells,
grown in suspension to a density of 2 x 106 cells per ml, were
pelleted by centrifugation at 1000 x g for 10 min, washed three
times with phosphate-buffered saline, and lysed in a hypotonic
lysis buffer (10 mM Tris HCl, pH 7.5/5 mM MgCl2/25 mM
NaF/1 mM EGTA/1 mM dithiothreitol/1 mM sodium or-
thovanadate containing aprotinin at 10 jig/ml, leupeptin at 10
,mg/ml, pepstatin at 0.5 ,ug/ml, chymostatin at 1 ,ug/ml, 1 mM
benzamidine, and 0.5 mM phenylmethanesulfonyl fluoride).
Soluble proteins from 1.5 x 109 cells were subjected to
immunoprecipitation with S jig of affinity-purified anti-14-
3-33 antibody, anti-cdc25A antibody, or preimmune rabbit
IgG. Immunoprecipitations were carried out essentially as
previously described (3).
Antibody against human 14-3-3,3 was raised against purified
MBP-14-3-313 fusion protein in rabbits and affinity purified on
a column containing Sepharose 4B-coupled, hexahistidine-
tagged human 14-3-3,3 (see below). Antibodies against Raf-1
(C20) were purchased from Santa Cruz Biotechnology. Anti-
bodies against cdc25A have been described (30). Samples for
detection of Raf-1 and cdc25A were analyzed on 7.5% poly-
acrylamide gels. Samples for detection of 14-3-3 were analyzed
on 12.5% gels.
Baculovirus Infections. A baculovirus which directs the
expression of the entire 14-3-313 protein was constructed with
the vector pLV1393 and the Baculo-gold kit (PharMingen).
This was used to infect Spodoptera frugiperda (Sf9) cells grown
in monolayer at a multiplicity of infection of 5, either alone or
in combination with viruses directing the expression of cdc25A
and Raf-1. Labeling with [35S]methionine indicated that ap-
proximately equal amounts of each protein were produced in
both doubly and triply infected cells. Insect cells were lysed at
60-72 h after infection in an NP40 lysis buffer (50 mM
Tris-HCl, pH 7.5/150 mM NaCl/0.5% Nonidet P-40/1 mM
dithiothreitol containing 1 mM sodium orthovanadate, apro-
tinin at 10 jig/ml, leupeptin at 10 ,ug/ml, pepstatin at 0.5
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Ag/ml, chymostatin at 1 Ag/ml, 1 mM benzamidine, and 0.5
mM phenylmethanesulfonyl fluoride). A soluble extract was
prepared by repeated passage of cells through a 26 gauge
needle followed by the removal of cellular debris by centrifu-
gation. Hexahistidine-tagged human 14-3-313 was prepared
from insect cells infected with a baculovirus expressing the
entire 14-3-313 protein fused in frame to the six-histidine tag
sequence of pAcSGHisNT-A (PharMingen).
RESULTS
Isolation of cdc25A-Binding Proteins. A two-hybrid screen-
ing was undertaken to identify proteins that physically interact
with the human cdc25 phosphatases. Human cdc25A and
cdc25B genes, fused in frame to the GAL4 DNA-binding
domain vector pGBT9, were each cotransformed into yeast
with a HeLa cell-derived cDNA library contained in the GAL4
transcriptional activation domain vector, pGADGH. Thirty-
four clones interacted with the cdc25 constructs sufficiently to
allow growth of the transformed host on media lacking histi-
dine and to express detectable levels of 13-galactosidase activ-
ity.
Among these positives were two members of the 14-3-3
family of proteins. One of 10 interaction-positive clones found
with cdc25A encoded the previously identified (34) 14-3-313
isoform (Fig. 1). Eight of 24 interaction-positive clones found
with cdc25B encoded the human homolog of the mouse
14-3-3E isoform (35). The complete nucleotide sequence of the
cDNA corresponding to the human 14-3-3E gene is shown in
Fig. 2. The deduced human 14-3-3e protein sequence is
identical to the mouse 14-3-3E sequence. Despite originating in
different screenings, both 14-3-3 clones interacted with either
cdc25 construct (Fig. 1). The interactions between 14-3-3 and
cdc25 constructs were judged to be specific, since interactions
between the GAL4AD-14-3-3 clones and GAL4DB gene fu-
sions with the human lamin gene or the S. cerevisiae SNFI gene
were not observed.
14-3-3 proteins have recently been implicated in a number
of mitogenic signaling pathways, including the kinase cascade
that contains Raf-1 (36-38). In Xenopus oocytes, increased
14-3-3 expression affects the Raf-1-dependent activation of
cdc2 duringXenopus maturation. We therefore tested for other
potential interactions between 14-3-3 clones and other players
in Raf-1 signal transduction and cell cycle control. The 14-3-3
clones and Raf-1, Ras, cdc2, cdk2, cdk4, and cdc25 proteins
were tested in pairwise combinations for protein-protein
interactions by using the two-hybrid assay. Both 14-3-3 clones
were capable of interacting with full-length Raf-1 as well as an
N-terminal deletion protein lacking amino acids 26-302 (Ta-
ble 1). Both clones also interacted with a C-terminal deletion
protein lacking amino acids 380-648, although growth on
plates lacking histidine was not as strong as in the case of
cdc25B
GADGH
FIG. 1. cdc25 proteins interact
with 14-3-3 proteins in the two-
1 4-3-3p hybrid screen. GAL4BD-cdc25 fu-
sion proteins and GAL4AD-14-3-3
fusion proteins interact jn yeast
cells, reconstituting functional
GAL4 transcriptional activator.
1 4-3-3E The expression of HIS3 from a
GAL4 promoter allows the his3
host to grow on media lacking his-
tidine. A GAL4 transcriptional ac-
tivation domain-Raf-1 fusion or a
vector control does not allow cells
to grow.
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AGAGTCGGAGCACTATCCGCTTCCATCCGTCGCGCAGACCCTGCCGGAGCCGCTGCCGCT
1 ATGGATGATCGAGAGGATCTGGTGTACCAGGCGAAGTTGGCCGAGCAGGCTGAGCGATAC
1 M D D R E D L V Y Q A K L A E Q A E R Y
61 GACGAAATGGTGGAGTCAATGAAGAAAGTAGCAGGGATGGATGTGGAGCTGACAGTTGAA
21 D E M V E S M K K V A G M D V E L T V E
121 GAAAGAAACCTCCTATCTGTTGCATATAAGAATGTAATTGGAGCTAGAAGAGCCTCCTGG
41 E R N L L S V A Y K N V I G A R R A S W
181 AGAATAATCAGCAGCATTGAACAGAAAGAAGAAAACAAGGGAGGAGAAGACAAGCTAAAA
61 R I I S S I E Q K E E N K G G E D K L K
241 ATGATTCGGGAATATCGGCAAATGGTTGAGACTGAGCTAAAGTTAATCTGTTGTGACATC
81 M I R E Y R Q M V E T E L K L I C C D I
301
101
361
121
CTGGATGTACTGGACAAACACCTCATTCCAGCAGCTAACACTGGCGAGTCCAAGGTTTTC
L D V L D K H L I P A A N T G E S K V F
TATTATAAAATGAAAGGGGACTACCACAGGTATCTGGCAGAATTTGCCACAGGAAACGAC
Y Y K M K G D Y H R Y L A E F A T G N D
421 AGGAAGGAGGCTGCGGAGAACAGCCTAGTGGCTTATAAAGCTGCTAGTGATATTGCAATG
141 R K E A A E N S L V A Y K A A S D I A M
481 ACAGAACTTCCACCAACGCATCCTATTCGCTTAGGTCTTGCTCTCAATTTTTCCGTATTC
161 T E L P P T H P I R L G L A L N F S V F
541
181
601
201
TACTACGAAATTCTTAATTCCCCTGACCGTGCCTGCAGGTTGGCTAAAGCAGCTTTTGAT
Y Y E I L N S P D R A C R L A K A A F D
GATGCAATTGCAGAACTGGATACGCTGAGTGAAGAAAGCTATAAGGACTCTACACTTATC
D A I A E L D T L S E E S Y K D S T L I
661 ATGCAGTTGTTACGTGATAATCTGACACTATGGACTTCAGACATGCAGGGTGACGGTGAA
221 M Q L L R D N L T L W T S D M Q G D G E
721 GAGCAGAATAAAGAAGCGCTGCAGGACGTGGAAGACGAAAATCAGTGAGACATAAGCCAA
241 E Q N K E A L Q D V E D E N Q *
781 CAAGAGAAACCATCTCTAACCACCCCCTCCTCCCCATCCCACCCTTTGGAAACTCCCCAT
841 TGTCACTGAGAACCACCAAATCTGACTTTTACATTTGGTCTCAGAATTTAGGTTCCTGCC
901 CTGTTGGTTTTTTTTTTTTTTTTTTAAAAGTTTTCAAAAGTTCTTAAAGGCAAGAGTGAA
961 TTT 963
60
20
120
40
180
60
240
80
300
100
360
120
420
140
480
160
540
180
600
200
660
220
720
240
780
260
840
900
960
FIG. 2. Sequence of the human 14-3-3s cDNA. The DNA sequence of both strands was determined by using an Applied Biosystems fluorescent
DNA sequencer. The deduced protein sequence is shown below the nucleotide sequence.
full-length Raf-1 or the N-terminal Raf-1 deletion. In general,
these results are similar to those previously reported for
14-3-3-Raf-1 interactions and indicates that the 14-3-36 iso-
form is similar to the 1B and C isoforms in terms of its ability to
interact with Raf-1 (36-38). None of the 14-3-3 clones or cdc25
clones interacted with Ras. Interactions between 14-3-3 pro-
teins and the human cdks also were not observed. Although
physical interaction between cdc25A or cdc25B and Raf-1 has
been observed in other experimental systems, we did not
detect an interaction between these proteins in the two-hybrid
assay. Taken together, these results indicate that only indirect
interactions were observed between the cell cycle control
components and the Ras pathway signaling components that
we tested with the two-hybrid assay. Although 14-3-3 inter-
acted with both Raf-1 and cdc25, we did not observe an
interaction between the cdc25s and Raf-1 even when human
14-3-3 was expressed in these cells.
14-3-3 Associates with cdc25A in Vitro and in Vivo. To
confirm the existence of a direct interaction between 14-3-3
and cdc25 proteins, the association was studied in a cell-free
system. Bacterially produced GST-cdc25A and MBP-14-3-3p3
fusion proteins were purified and found to associate in vitro
(Fig. 3A). Interactions between the GST and MBP moieties
were not observed. This indicates that the two proteins are
capable of directly interacting without the Ras/mitogen-
activated protein kinase kinase signaling pathway components
that are present in yeast cells (39).
Both proteins were also found to associate in vivo. Fig. 3B
shows that cdc25A protein is precipitated from the soluble
fraction of HeLa cells with anti-cdc25A antibody or anti-14-
Table 1. Summary of interactions between cdc25 phosphatases, 14-3-3 proteins, and Raf-1 domains in the two-hybrid screen
aBinding domainActivation
domain cdc25A cdc25B cdc2 cdk2 cdk4 RAF-1 RAFAN1 RAFAC1 RASC186R
GADGH - - - - - - - _
cdc25A ND ND - - - - - -
cdc25B ND ND - + - - - -
14-3-3(3 + + - - - + + +
14-3-3s + + - - - + + +
Raf-1 - - - - - ND ND ND +
Raf K375W - - - - - ND ND ND +
Rows list coding regions fused to the GAL4 DNA activation domain plasmid pGADGH. Columns list coding regions fused to the GAL4
DNA-binding domain plasmids except for Raf-1 deletions, which were lex DNA-binding domain fusions. + indicates interaction of the two constructs
as evidenced by the ability to form colonies on plates lacking histidine; - indicates no growth and therefore no interaction; and ND signifies not
determined. Plasmids carrying Ras and Raf-i fusions were gifts of L. VanAelst (33).
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FIG. 3. Interaction between 14-3-3,B and cdc25A proteins. (A)
Purified bacterially produced MBP-14-3-3,3, which migrates as a
doublet, is precipitated by purified bacterially produced GST-cdc25A
and glutathione-Sepharose beads in vitro. a indicates an antibody. (B)
Co-immunoprecipitation of 14-3-3 and cdc25 from the soluble fraction
of HeLa cells with anti-14-3-3,8 antibody. Protein preparations and
immunoprecipitations were as described in the text. Equal volumes of
sample from equal volumes of protein A-Sepharose beads were loaded
in each lane. The gel was blotted and probed with anti-cdc25A
antibody.
3-3,B antibody. Co-immunoprecipitation of human cdc25A
with anti-14-3-313 antibody indicates that the two proteins are
associated in human cells. Immunoprecipitation with anti-14-
3-3,B antibody depleted -5% of the soluble cdc25A from HeLa
lysates. This was similar to the amount of Raf-1 protein that we
could precipitate from HeLa lysates under the same conditions
with the anti-14-3-3X3 antibody (data not shown). Although
Raf-1-14-3-3 interactions have been observed in membrane
fractions of cells (38), the existence of cdc25A-14-3-3 mem-
brane-bound complexes could not be addressed due 'to a
difficulty inherent in the immunoprecipitation of cdc25A from
membrane preparations (30).
14-3-3 Associates with cdc25A and Raf-1 in Insect Cells. We
also tested the interaction between cdc25A and 14-3-3, by
using baculovirus-produced proteins in insect cells, where
interactions with Raf-1 could also be assessed. All pairwise
associations between Raf-1, cdc25A, and 14-3-3(3 proteins
were observed. 14-3-313 could be co-immunoprecipitated with
antibodies to either Raf-1 (Fig. 4, a14-3-3 panel, lanes 3 and
4) or cdc25A (Fig. 4, a14-3-3 panel, lanes 7 and 8). Similarly,
Raf-1 and cdc25 could be precipitated with anti-human 14-
3-313 antibody. All possible combinations of co-immunopre-
cipitation were also observed in triple infections. However, it
was not possible to determine whether co-immunoprecipita-
tion of all three proteins represented precipitation of triple
complexes (14-3-3,--Raf-1-cdc25A) or multiple pairwise com-
plexes (14-3-33-Raf-1, Raf-1-cdc25A, or 14-3-31-cdc25A).
We consistently observed an approximate 2.5-fold increase in
the amount of Raf-1-cdc25A precipitable complex in cells
infected with 14-3-313 construct versus cells infected with only
Raf-1 and cdc25A (Fig. 4, aRaf-1 panel, lane 9 vs. lane 6;
acdc25A panel, lane 5 vs. lane 2). This may represent an
underestimate of the increase in binding between Raf-1 and
cdc25A, since Raf-1-cdc25A complex formation in doubly
infected cells may be stimulated by insect cell 14-3-3 protein.
Insect cell 14-3-3 protein, which cross-reacted with the anti-
14-3-313 antibody, was also observed binding to Raf-1 (Fig. 4,
a14-3-3 panel, lanes 2 and 5; refs. 38 and 40) and could
,;;;=s, ~~~~~~~~~~~~~~~~~~~~~....^...... ...;.,
, '.
acdc25A
al 4-3-3p
FIG. 4. Associations between recombinant human Raf-1, 14-3-3,
and cdc25A proteins in insect cells. Cell lysate preparation and
immunoprecipitation were carried out as described in the text. Equal
volumes of sample from equal volumes of protein A-Sepharose beads
were loaded in each lane. Gels were blotted and probed with anti-
bodies (a) indicated. P.I., preimmune serum. Only blot regions
corresponding to proteins of interest are shown. Signal found in lanes
2 and 5 of the a14-3-3 panel corresponds to insect cell 14-3-3 protein
(38, 40).
potentially assist in complex formation in the absence of
baculovirus-expressed 14-3-3.
DISCUSSION
14-3-3 proteins have been isolated in a yeast two-hybrid screen
designed to identify proteins that interact with human cdc25
phosphatases. The 14-3-313 isoform has been found to physi-
cally associate with cdc25A both in vivo and in vitro. The
consequence of the observed interaction between 14-3-3 and
cdc25, however, is not fully understood. Although once be-
lieved to be a nuclear protein present in cells only after
mitogenic stimulation (28, 29), cdc25A has been found to
associate with Raf-1 at or near the plasma membrane imme-
diately after the stimulation of quiescent cells (30). Since
Raf-1-dependent kinase activity also phosphorylates and stim-
ulates cdc25A activity, cdc25A is thought' to mediate, at least
in part, cell cycle activation by the Ras/Raf-1 pathway (30).
14-3-3 proteins, including the 14-3-313 isoform which interacts
with the cdc25s, have, in some cases, been shown to stimulate
Raf-1 kinase activity (40, 41). We did not, however, observe
consistent 14-3-3-dependent stimulation of cdc25A phosphor-
ylation by Raf-1 which was prepared by immunoprecipitation
from insect cells triply infected with Raf-1, Ras, and Src
baculoviruses (42). We were also unable to detect any effect of
14-3-3 on cdc25A phosphatase activity in vitro.
That 14-3-3 proteins have been found to physically interact
with a cell cycle regulatory element is not surprising. 14-3-3
proteins have been implicated in the regulation of cell cycle
control in Xenopus oocytes and in fission yeast. A direct
physical interaction between 14-3-3 and cdc25 proteins is
generally consistent with the observed effects of 14-3-3 pro-
teins on cell cycle control. In Xenopus oocytes, 14-3-3 proteins
have a positive effect on the Raf-1-dependent activation of
cdc2 (37). We did not observe interaction between 14-3-3
proteins and cyclin-dependent kinases in two-hybrid assays.
Since cdc25 is also well established as a primary regulator of
cdc2 activity in Xenopus, it is possible that the stimulatory
effect of 14-3-3 on cdc2 activity may be mediated by Raf-1-
dependent stimulation of cdc25 phosphatase activity. In fission
yeast, 14-3-3 proteins are required for a DNA damage-induced
cell cycle checkpoint (43) and for the correct timing'of mitosis.
Although a direct connection between 14-3-3 and cdc25 pro-
teins has not been established genetically in fission yeast, the
Cell Biology: Conklin et al.
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cdc25 gene has been firmly established as a regulator of the
timing of mitosis (44) and has been implicated in checkpoint
control (45). It'should be noted, however, that 14-3-3 proteins
appear to have a positive effect on cell cycle progression in
higher cells (37, 38, 41, 46, 47) and a negative effect on cell
cycle progression in fission yeast (43). More information on the
function of 14-3-3 proteins should resolve this paradox.
14-3-3 proteins have been shown to associate with a number
of proteins involved in the cellular response to mitogenic
factors, including Raf-1 (38, 40, 41), Bcr-Abl (46), and middle
T antigen (47). The consequences of 14-3-3 binding by these
mitogenic signal transduction proteins are not fully known.
Moreover, the determination of the effect of 14-3-3 binding
has been hampered by the bewildering number of biochemical
activities related to signal transduction that 14-3-3 proteins
have been shown to possess (48). These include ADP-
ribosyltransferase activity (49), phospholipase A2 activity (50),
Ca2+ binding (50), activation and inhibition of protein kinase
C (51), activation of amino acid hydroxylases in neurotrans-
mitter synthesis (52), and stimulation of secretion (53). At
present, it seems difficult to attribute all of these activities to
a single 30-kDa protein, or even to a subset of this highly
conserved family.
On the basis of the studies of interaction between 14-3-3
proteins and the Raf-1, Bcr-Abl, and middle T antigen pro-
teins, it has been suggested that 14-3-3 proteins play an
organizational role in mitogenic signal transduction (36). The
modest increase in Raf-1-cdc25A complex formation ob-
served in insect cells expressing high levels of 14-3-3 is
consistent with this hypothesis. That we did not observe
increased Raf-1-cdc25A interaction in vitro in the presence of
either bacterially produced or baculovirus-produced 14-3-3
protein suggests that 14-3-3 may require other cellular com-
ponents such as membranes or submembranous cytoskeletal
structures similar to those containing Raf-1 (54), to stimulate
Raf-1-cdc25A complex formation. Whether 14-3-3 stimulates
Raf-1-cdc25A complex formation in human cells is not known.
Nevertheless, the physical association of 14-3-3 proteins with
cdc25 phosphatases offers further evidence for the interaction
between mitogenic signaling and cdc25-dependent cell cycle
control.
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